The Series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of AstraZeneca PLC (the “Company”). The Series will not invest directly in the Company. ADRs are receipts, issued by an American bank or trust issuer, which evidence ownership of underlying securities issued by a non-U.S. issuer. The fund is non-diversified.

Company Data

Name Precidian ETFs Trust AstraZeneca PLC ADRhedged

Company AstraZeneca PLC ADRHedged ETF

Symbol AZNH

Website https://www.astrazeneca.com

Primary Exchange

NYSE

ISIN US74016W3043

Asset Class ETF

Sector Healthcare

Industry Medical - Pharmaceuticals

Country United Kingdom

Currency USD

Employees -

Address Cambridge Biomedical Campus, Cambridge

IPO Date 2024-10-07

Ticker Symbols

Name	Symbol
NYSE	AZNH

More Shares

Investors who hold Precidian ETFs Trust AstraZeneca PLC ADRhedged also have the following shares in their portfolio:

Grand Foundry Limited Share

PFZ.SCHW.KTB 20/28 ZO Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog